BioCatalyst

AVIR — Atea Pharmaceuticals, Inc. catalysts

1 verified catalyst event(s) for Atea Pharmaceuticals, Inc. (ticker AVIR). Each is linked to its official source. Verified as of 2026-06-22.

Next verified catalyst

2026-09-01 — C-BEYOND: Efficacy and Safety of BEM/RZR vs. SOF/VEL in Subjects With Chronic HCV · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-09 (month)
in 2mo
ESTIMATED
 READOUT
C-BEYOND: Efficacy and Safety of BEM/RZR vs. SOF/VEL in Subjects With Chronic HC
Phase 3 · HEPATITIS C VIRUS CHRONIC INFECTION
 AVIR Atea Pharmaceuticals, Inc. Bemnifosbuvir-Ruzasvir (BEM/RZR), Sofosb ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.